 |
|
|
| |
Proton-pump inhibitor omeprazole did not affect the plasma pharmacokinetics of bemnifosbuvir and ruzasvir fixed-dose combination in healthy participants
|
| |
| |
EASL 2026 May 26-30 Barcelona
Xiao-Jian Zhou,1 Brett Smith,2 Maureen Montrond,1 Keith Pietropaolo,1 Bruce Belanger,1 Shannan Lynch,1 Dayle James,1 Maria Arantxa Horga,1 Janet Hammond1
1. Atea Pharmaceuticals, Inc., Boston, USA; 2. Altasciences, Los Angeles, USA.
|
| |
|
|
|
|
|
